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PTEN regulates the ubiquitin-dependent degradation of the CDK
inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2
Ramanaiah Mamillapalli*, Nadia Gavrilova*, Valia T. Mihaylova*,
Lyuben M. Tsvetkov*, Hong Wu†, Hui Zhang* and Hong Sun*
The PTEN tumor suppressor acts as a phosphatase the levels of p27KIP1. To efficiently express PTEN and
examine its cell cycle effects, we have reintroduced thefor phosphatidylinositol-3,4,5-trisphosphate
(PIP3) [1, 2]. We have shown previously that PTEN Pten gene into a PTEN-deficient human glioblastoma
cell line, U87MG, by using recombinant retroviruses [3].negatively controls the G1/S cell cycle transition
and regulates the levels of p27KIP1, a CDK inhibitor Expression of PTEN led to the selective accumulation
of p27 [3] (Figure 1a), while the levels of cyclin E were[3, 4]. Recently, we and others have identified an
ubiquitin E3 ligase, the SCFSKP2 complex, that not affected by PTEN status (Figure 1a). Expression
of either a PTEN lipid phosphatase–inactive mutant,mediates p27 ubiquitin-dependent proteolysis
[5–7]. Here we report that PTEN and the PI 3-kinase G129E [8, 9], or the catalytically inactive C124S mutant
[3] failed to induce p27KIP1 (Figure 1a). The treatment ofpathway regulate p27 protein stability. PTEN-
deficiency in mouse embryonic stem (ES) cells U87 cells with a specific pharmacologic inhibitor for PI
3-kinase, LY294002, also led to the selective accumulationcauses a decrease of p27 levels with concomitant
increase of SKP2, a key component of the SCFSKP2 of p27 (Figure 1a). The specific effect of PTEN on PIP3
was further confirmed by the reduced phosphorylation ofcomplex. Conversely, in human glioblastoma cells,
ectopic PTEN expression leads to p27 accumulation, Akt, a downstream signaling molecule of the PI 3-kinase
pathway (Figure 1a).which is accompanied by a reduction of SKP2. We
found that ectopic expression of SKP2 alone is
sufficient to reverse PTEN-induced p27 Accumulation of p27 could occur at the levels of either
accumulation, restore the kinase activity of cyclin mRNA or protein. Northern-blot analysis indicates that
E/CDK2, and partially overcome the PTEN-induced PTEN and PI 3-kinase regulate p27 at a posttranscrip-
G1 cell cycle arrest. Consistently, recombinant tional level (Figure 1b). Characterization of p27 levels in
SCFSKP2 complex or SKP2 protein alone can rescue the presence of cycloheximide or pulse-chase experi-
the defect in p27 ubiquitination in extracts ments revealed that p27 protein stability is increased in
prepared from cells treated with a PI 3-kinase the cells expressing PTEN (Figure 1c,d). Recent studies
inhibitor. Our findings suggest that SKP2 functions have shown that the protein stability of p27 is regulated
as a critical component in the PTEN/PI 3-kinase by the SCFSKP2 ubiquitin E3 ligase complex [5–7]. Exami-
pathway for the regulation of p27KIP1 and cell nation of the levels of SKP1, SKP2, and CUL-1 of the
proliferation. SCFSKP2 complex indicates that SKP2, the substrate-tar-
geting subunit of SCFSKP2, was markedly downregulated*Department of Genetics, Yale University School of Medicine, New
by the expression of wild-type PTEN or by exposure toHaven, Connecticut 06520, USA. †Department of Molecular and
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of Medicine, Los Angeles, California 90095, USA. tently, there was a significant increase of the SKP2 level
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To determine whether SKP2 is a critical target for the
PTEN pathway that regulates p27KIP1 levels, we tested
whether expression of SKP2 in U87 cells is sufficient to
restore p27 levels when PTEN is present. As shown inResults and discussion
To determine how PTEN regulates cell cycle progression, Figure 2a, while PTEN induced high levels of p27, ex-
pression of SKP2 together with PTEN completely sup-we investigated the mechanism by which PTEN controls
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Figure 1
PTEN and PI 3-kinase regulate the levels of p27 and SKP2. (a) U87- each sample was subjected to Northern blot analysis with the indicated
EcoR cells were infected with retroviruses carrying either an empty probes. (c,d) U87-EcoR cells were infected with vector control
vector, wild-type PTEN cDNA, PTEN C124S (CS), or G129E (GE) viruses or PTEN viruses for 48 hr. (c) Cells were then treated with
mutants (lanes 1–4) and were harvested at 48 hr post-infection. 50 mg/ml cycloheximide (CYH) for the indicated times, and cell
Alternatively, U87-EcoR cells were treated with vehicle DMSO or lysates (50 mg each) were examined by Western blot analysis with
LY294002 (20 mM) for 24 hr (lane 5 and 6). In lanes 7 and 8, an anti-p27 antibody. (d) Alternatively, cells were pulse labeled with
lysates were prepared from actively growng Pten1/1 and Pten2/2 [35S]methionine for 1 hr and were then chased in the regular medium
mouse ES cells. Cell lysates (50 mg each) were examined for the supplemented with 7.5 mg/ml methionine for 0, 1, 2, or 4 hr. Cell
indicated cell cycle regulators by Western blot analysis with the lysates were subjected to immunoprecipitation with an anti-p27
corresponding antibodies. (b) U87-EcoR cells were infected with antibody, and the immunoprecipitates were analyzed by SDS-PAGE
retroviruses carrying an empty vector or PTEN, or they were treated and fluorography.
with vehicle DMSO or LY294002 (20 mM). Total RNA (10 mg) from
pressed the PTEN-induced p27 accumulation. On the and Figure 2b). This result suggests that cyclin E itself,
in the absence of SKP2, is not sufficient to trigger theother hand, Akt phosphorylation was still inhibited by
PTEN, either in the presence or absence of SKP2, and degradation of p27. Expression of CDK2 also failed to
rescue the p27 downregulation defect in the PTEN-this finding suggests that PIP3 levels remained low. It
has been shown that cyclin E/CDK2 can phosphorylate expressing cells (data not shown). In addition, expres-
sion of cyclin E or CDK2 did not further enhance thep27 on threonine 187 (Thr 187) [10, 11], and the Thr 187
phosphorylation is essential for the subsequent degrada- effect of SKP2 on the downregulation of p27 (Figure 2a).
The observation that SKP2, but not cyclin E or CDK2,tion of p27 [5–7, 10, 11]. In PTEN-expressing cells, p27
accumulation led to the inhibition of cyclin E–associated can reverse the effect of PTEN on p27 accumulation
suggests that SKP2 is a rate-limiting factor in p27 ubiquiti-kinase activity (see below and Figure 2b), while the pro-
tein level of cyclin E was not affected by PTEN expres- nation and degradation and that PTEN regulates this
process.sion (Figure 1a). We found that ectopic expression of
cyclin E failed to downregulate p27 in PTEN-expressing
U87 cells (Figure 2a), although the expressed cyclin E It is established that the critical function of p27KIP1 in the
late G1 phase of the cell cycle is to inhibit the kinaseresulted in the restoration of the cyclin E/CDK2 kinase
activity that was originally inhibited by PTEN (see below activity of cyclin E/CDK2 and thus to prevent premature
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Figure 2
SKP2 suppresses p27 accumulation
mediated by PTEN expression. (a,b) U87-EcoR
cells were infected either alone with vector
control viruses or PTEN viruses or together
with retroviruses expressing SKP2, cyclin E or
CDK2 in combinations as indicated. (a) Forty-
eight hours postinfection, cells were
harvested, and cell lysates (50 mg each) were
subjected to Western blot analysis with the
indicated antibodies. (b) Cell lysates (500
mg each) were subjected to
immunoprecipitation with anti-cyclin E
antibodies. We assayed the
immunoprecipitated kinases for activities by
using histone H1 as a substrate in the
presence of 32P-[g]-ATP, and we processed
them by using SDS-PAGE and
autoradiography. (c) U87-EcoR cells were
infected with retroviruses expressing PTEN or
together with retroviruses expressing cyclin
E. Alternatively, cells were infected with
retroviruses carrying either an empty vector,
wild-type PTEN, PTEN C124S (CS), or
G129E (GE) mutants. Cell lysates (50 mg
each) were examined by Western blot analysis
with an antibody specific for the T187-
phosphorylated p27 or with a regular anti-p27
antibody. (d) U87-EcoR cells were infected
with retroviruses carrying either an empty
vector or SKP2DN. Cells were harvested 48
hr postinfection, and cell lysates (50 mg each)
were subjected to Western blot analysis with
the indicated antibodies.
entry into S phase [12]. We examined whether SKP2- Previous studies indicate that SCFSKP2-mediated p27 deg-
radation is dependent on the presence of phosphorylatedmediated rescue of p27 degradation in PTEN-expressing
cells is sufficient to restore the cyclin E/CDK2 kinase Thr 187 in p27 and that cyclin E/CDK2 can phosphorylate
Thr 187 in p27 [5–7, 10, 11]. Our finding that SKP2activity. Indeed, while PTEN expression led to the inhi-
bition of cyclin E/CDK2 kinase activity, coexpression of expression alone is sufficient to rescue the p27 degrada-
tion defect in PTEN-expressing cells suggests that theSKP2 fully relieved such an inhibition (Figure 2b). When
cyclin E was coexpressed with PTEN, the cyclin E/CDK Thr 187 residue of p27 is still phosphorylated even when
the kinase activity of cyclin E/CDK2 is inhibited. Tokinase activity was higher than that in the vector control
cells, as one would expect if the ectopically expressed examine the Thr 187 phosphorylation status of p27, we
used an antibody that is specific for Thr 187–phos-cyclin E were not completely inhibited by the endogenous
p27 (Figure 2b). When SKP2 and cyclin E were coex- phorylated p27 [7]. To confirm the specificity of this anti-
body, we coexpressed cyclin E with PTEN. We reasonedpressed together with PTEN, a further increase of cyclin
E/CDK2 kinase activity was observed, as compared with that under this condition, Thr 187–phosphorylated p27
should increase as a result of the restored cyclin E/CDK2that of expressing SKP2 or cyclin E alone in the presence
of PTEN (Figure 2b). This result suggests that SKP2 can kinase activity (Figure 2b). Indeed, we found that there
was a higher level of the Thr 187–phosphorylated p27further activate the cyclin E/CDK2 activity, likely through
its effect on p27 degradation. In addition, SKP2 can simi- when cyclin E was coexpressed with PTEN than when
PTEN was expressed alone (Figure 2c). Using this anti-larly fully suppress p27 accumulation in cells treated with
the PI 3-kinase inhibitor LY294002 and can recover cyclin body, we observed that in the PTEN-expressing cells,
the levels of Thr 187–phosphorylated p27 were similar toE/CDK2 kinase activity in these cells (See Supplementary
material, Figure S1, available with this article on the in- those in the vector or the PTEN mutant controls (Figure
2c) even though cyclin E/CDK2 kinase activity was nearlyternet). The ability of SKP2 to fully rescue the cyclin
E/CDK2 kinase activity in the PTEN-expressing cells or completely inhibited when PTEN was present (see Fig-
ure 2b). These results raise the possibility that other ki-LY294002-treated cells suggests that SKP2-mediated p27
downregulation in these cells plays an important role in nase(s), in addition to cyclin E/CDK2, may be involved
in the phosphorylation of p27. The steady-state levels ofthe activation of cyclin E/CDK2.
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Figure 3
Inhibition of PI 3-kinase affects p27 ubiquitination. Cell extracts were ubiquitin analogs ubiquitin aldehyde and methylated ubiquitin. Where
prepared from actively growing U87-EcoR cells (control extract) or indicated, the purified recombinant cyclin E/CDK2 complex, the
cells that had been treated with LY294002 for 24 hr (LY extract). SCFSKP2 complex, or the SKP2 protein itself were also added to the
[35S]p27 was incubated with the corresponding extracts at 308C reactions. The reaction products were immunoprecipitated with anti-
for 0 or 3 hr in the presence of ATP regeneration system and the p27 antibodies and were analyzed by SDS-PAGE and fluorography.
the phosphorylated p27 in cells are thus a combination
of the activities of these kinases.
Figure 4
To further determine the function of the endogenous
SKP2 in the regulation of p27 in U87 cells, we expressed
a dominant negative form of SKP2 (SKP2DN) that con-
tains a deletion in the F box region known to be involved
in the binding of SKP2 to the SKP1/Cul-1 complex [7].
Expression of SKP2DN in U87 cells led to accumulation
of endogenous p27, while the levels of cyclin D were not
affected (Figure 2d). These results further strengthen
the notion that downregulation of SKP2 levels by PTEN
expression is mechanistically linked to the p27 accumula-
tion in these cells.
To further investigate whether PTEN regulates the ubiq-
uitin-dependent degradation of p27 through the SCFSKP2
complex, we examined the consequences of PI 3-kinase
inhibition in an in vitro p27 ubiquitination assay [5]. As
shown in Figure 3a, while the extracts prepared from
actively growing U87 cells (control extract) readily ubiqui-
tinated p27 in the presence of cyclin E/CDK2, the extracts
Rescue of the S phase entry defect in PTEN-expressing cells by SKP2.prepared from LY294002-pretreated cells (LY extracts)
U87-EcoR cells were infected alone with vector control viruses orhad very little ubiquitination activity under the same con- PTEN viruses or together with retroviruses expressing SKP2, cyclin
ditions (Figure 3a). The addition of the purified recombi- E, or CDK2 in combinations as indicated. Fifty-seven hours
postinfection, cells were pulse labeled with BrdU for 3 hr and werenant SCFSKP2 complex or SKP2 alone fully restored p27
then harvested for the cell cycle profile with the fluoresence-activatedubiquitination activity in the LY extracts (Figure 3a,b).
cell-sorting analysis. The percentages (vertical axis) of cells in G0/G1,These experiments suggest that PTEN and the PI S, or G2/M phases (horizontal axis) in the corresponding samples are
3-kinase signaling pathway function through SKP2, a key presented. The data shown are averages of a duplicate set of
experiments, and the standard deviations are indicated.component of the SCFSKP2 E3 ligase, to regulate the ubiq-
uitin-dependent proteolysis of p27.
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SCF(Skp2) complex through phosphorylated thr187 in p27.We have shown previously that ectopic expression of
Curr Biol 1999, 9:661-664.
PTEN blocks the G1-to-S-phase cell cycle progression, 6. Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller
U, et al.: p45(Skp2) promotes p27(Kip1) degradation and induceswhich is accompanied by the increase of p27KIP1 [3]. To
S phase in quiescent cells. Nat Cell Biol 1999, 1:207-214.determine the contribution of p27 accumulation in PTEN- 7. Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for
mediated G1 cell cycle arrest, we examined whether the ubiquitin-mediated degradation of the CDK inhibitor p27.
Nat Cell Biol 1999, 1:193-199.rescue of the p27 degradation defects by SKP2 is sufficient
8. Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1,
to allow cells to enter S phase. As shown in Figure 4, dephosphorylates the lipid second messenger,
phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998,PTEN expression in U87 cells reduced the S phase popu-
273:13375-13378.lation from 33% to 12%, with a concomitant increase of the 9. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings
G1 phase population. Coexpression of SKP2 and PTEN BA, et al.: The lipid phosphatase activity of PTEN is critical for
its tumor supressor function. Proc Natl Acad Sci USA 1998,partially rescued the PTEN-mediated G1 phase arrest,
95:13513-13518.while the S phase population increased to 20%. Coexpres- 10. Sheaff RJ, Groudine M, Gordon M, Roberts J M, and Clurman BE:
Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997,sion of cyclin E and PTEN rescued the PTEN-mediated
11:1464-1478.G1 arrest and increased the S phase population to 30%,
11. Vlach J, Hennecke S, Amati B: Phosphorylation-dependent
although p27 levels remained high under such conditions degradation of the cyclin-dependent kinase inhibitor p27.
Embo J 1997, 16:5334-5344.(Figure 2). The coexpression of SKP2 and cyclin E has
12. Sherr CJ, Roberts JM: CDK inhibitors: positive and negativea more profound effect on promoting S phase entry than regulators of G1-phase progression. Genes Dev 1999,
does the expression of either SKP2 or cyclin E alone, with 13:1501-1512.
58% of cells in the S phase even when PTEN was present.
The partial rescue of S phase by SKP2 suggests that the
induction of SKP2 by the PI 3-kinase pathway constitutes
an important, but not the only, event required for the
G1-to-S-phase cell cycle transition. Since high levels of
cyclin E/CDK2 kinase activity can effectively promote S
phase entry in PTEN-expressing cells, it suggests that
there may be additional PI 3-kinase signaling events in-
volved in cyclin E/CDK2 activation. Alternatively, the
increased cyclin E/CDK2 kinase activity may substitute
for functions of other kinases to promote G1/S transition.
In summary, our findings suggest that SKP2 functions as
a critical component in the PTEN/PI 3-kinase pathway
for the regulation of p27KIP1 and cell proliferation.
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Supplementary materials and methods as well as a supplementary figure
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